VX-680 (MK-0457,Tozasertib)

VX-680 (MK-0457,Tozasertib)

Catalog Number:
L002369023APE
Mfr. No.:
APE-A4111
Price:
$204
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          VX-680 (also known as MK-0457 or tozasertib), discovered through a molecular screening campaign, is a potent inhibitor of pan-aurora kinase as well as other kinases including Src, GSK3β, Flt3, JAK2, BCR-Abl (wild type) and BCR-Abl (T315I mutant). It binds to the inactive conformations of non-aurora kinases preventing activation, which leads to the inhibition of a wide array of kinases. Having been extensively investigated in cell lines and/or xenografts in animal models, VX-680 exhibits high degree of anti-tumor activity against a broad spectrum of tumor types, including ovarian, renal cell carcinoma, thyroid, oral squamous cell, CML (wild-type and mutant BCR-Abl), AML, and MM.

      • Properties
        • Alternative Name
          N-[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide
          CAS Number
          639089-54-6
          Molecular Formula
          C23H28N8OS
          Molecular Weight
          464.59
          Appearance
          A solid
          Purity
          98.07%
          Solubility
          ≥23.25 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O
          Storage
          Store at -20°C

          * For Research Use Only

    We Also Recommend

    MLN8054

    $276

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.